Are Femoral Stems in Primary Total Knee Arthroplasty Cost Effective in High Fracture Risk Patients? A Risk Model and Cost Analysis

Abstract

Introduction: Femoral stemmed total knee arthroplasty (FS TKA) may be used in patients deemed higher risk for periprosthetic fracture (PPF) to reduce PPF risk. However, the cost effectiveness of FS TKA has not been defined. Using a risk modeling analysis, we investigate the cost effectiveness of FS in primary TKA compared to the implant cost of revision to distal femoral replacement (DFR) following PPF. Methods: A model of risk categories was created representing patients at increasing fracture risk, ranging from 2.5%-30%. The number needed to treat (NNT) was calculated for each risk category, which was multiplied by the increased cost of FS TKA and compared with the cost of DFR. 50th percentile implant pricing data for primary TKA, FS TKA, and DFR was identified and used for the analysis. Results: FS TKA resulted in an increased cost of $2,717.83, compared to the increased implant cost of DFR of $27,222.29. At 50% Relative Risk Reduction (RRR) with FS TKA, the NNT for risk categories of 2.5%, 10%, 20%, and 30% were 80, 20, 10, and 6.67 respectively. At 20% risk, FS TKA times NNT equaled $27,178.30. A 10% Absolute Risk Reduction (ARR) in fracture risk obtained with FS TKA is needed to achieve cost neutrality with DFR. Conclusion: FS TKA is not cost effective for low fracture risk patients but may be cost effective for patients with fracture risk greater than 20%. Further study is needed to better define the quantifiable risk reduction achieved in using FS TKA, and identify high risk PPF patients.